# CBC Group

CBC Group is an Asset Manager based in Singapore, Singapore.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.cbridgecap.com
- **LinkedIn:** https://www.linkedin.com/company/cbcgroup-sg
- **Wikidata:** Q120670267

## Regulatory record

- **Reports private funds:** No

## About

CBC Group is a healthcare-dedicated asset management firm founded in 2014 in Singapore. It operates in sectors including platform-building, buyout, private credit, venture, and real estate within the healthcare industry. CBC Group has made 44 investments and 12 portfolio exits, with its latest investment in Santhera Pharmaceuticals on September 23, 2025, and its latest portfolio exit in MiRXES on May 23, 2025.

## Sectors

- Healthcare Services
- Pharmaceuticals & Biotech
- Medical Devices
- Healthcare IT

## Offices

- Beijing, China
- Shanghai, China
- Hong Kong

## People

- Weijian Shan — Co-Founder, Chairman & CEO

## Questions

### Who makes the final investment decisions at CBC Group?

Weijian Shan, the firm's Co-Founder and Chairman, chairs the investment committee and holds final decision-making authority on new commitments. Shan's four decades in private equity — spanning TPG, Newbridge Capital, and his academic career — make him the central figure in both origination and approval. The committee includes senior partners with operating and clinical expertise.

### Does CBC Group invest outside healthcare?

No. CBC Group is structurally a healthcare-only investment firm. Its mandate covers pharmaceuticals, biotechnology, medical devices, healthcare services, and related health-tech businesses, exclusively. The firm does not opportunistically pursue deals in consumer, industrials, or technology sectors.

### How does CBC Group source proprietary healthcare deals in China?

CBC relies on a combination of deep government and regulatory relationships, an in-house team of clinical advisors who track drug-approval pipelines, and a network of hospital-group founders built over two decades by Weijian Shan. The firm also uses its operating-partner bench to identify roll-up targets inside fragmented sub-sectors like specialty pharmacy and in-vitro diagnostics.

### Where does CBC Group's capital come from?

CBC raises capital from global institutional limited partners, including North American and European pension funds, sovereign wealth funds, endowments, and family offices. The firm does not manage a single family's wealth, distinguishing it from a family-office structure. Capital is pooled into blind-pool drawdown funds with a standard private-equity fee and carry structure.

### How does the R-Bridge platform fit into CBC's broader strategy?

R-Bridge Healthcare serves as CBC's specialty pharmaceutical and medical-device distribution platform in mainland China. Rather than waiting for portfolio companies to build their own sales forces, CBC can plug acquisitions into R-Bridge's existing commercial infrastructure — accelerating revenue growth and providing a turnkey route to Chinese hospitals and clinics.

## Related profiles

- [Cava Capital](https://altss.com/profile/cava-capital)
- [CCB Life Insurance Asset Management](https://altss.com/profile/ccb-life-insurance-asset-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cbc-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology